Skip to main content

Team Maureen


Vaccine News

A 20-year study on dozens of vaccines finds they are safer than 'almost any other modern medical intervention'

A comprehensive new study spanning 20 years and 57 vaccines finds vaccines are "remarkably safe" — safer, in fact, than "almost any other modern medical intervention," lead author Dr. Daniel Shepshelovich told Business Insider.

For the study, he and other researchers at Tel Aviv Sourasky Medical Center looked at the labels, including safety-related changes, of 57 vaccines that became FDA-approved between the beginning of 1996 and end of 2015.

Vaccine Rates Drop Dangerously as Parents Avoid Doctor’s Visits

Afraid of Covid-19, parents are postponing well-child checkups, including shots, putting millions of children at risk of exposure to preventable deadly diseases.

Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types

More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the vaccine, HPV16 and 18. The new findings are from an extended follow-up of the NCI-sponsored Costa Rica HPV Vaccine Trial.

Take the Shot Nights at Falmouth High School and Mashpee High School

Taking a Shot at HPV Prevention!

Young fans who attend the Falmouth High girls’ basketball game on Jan. 31 and the Mashpee High boys’ basketball game on Feb. 14 will have the opportunity to spin a prize wheel and participate in a halftime basketball free-throw contest.

At the 3rd Annual “Take the Shot Night,” they will also, along with their parents/guardians, learn about a different shot that will protect them from the HPV virus and HPV-related cancers.

Years after Texas backed off HPV vaccine mandate, cervical cancer rate soars

Texas and Australia took two very different paths in 2007. And the difference is unbelievable. Continue to Article

Human Papillomavirus Vaccination for Adults: Updated Recommendations

Study: HPV Vaccine Works

A new meta-analysis published in The Lancet in June shows the HPV vaccine is very effective and is expected to lower the rate of cervical and other related cancers.

The researchers reviewed data from 60 million young men and women in 14 high-income nations, with up to 8 years of post-vaccination follow-up. Continue to the Cape Cod Health News Article.

British boys will receive HPV vaccine to prevent 'thousands of cancers'

London (CNN)Boys aged 12 and 13 will be offered the HPV vaccine in all British schools from September, in a move health officials say will prevent thousands of cancer cases. Continue to Article

KIDS' HEALTH HPV vaccine benefits 'exceed expectations,' may lead to elimination of cervical cancer

End cervical cancer? The HPV vaccine could do it, study suggests

More than 10 years after it became widely available to the public, a recent analysis of prior studies confirms one thing: The HPV vaccine may be a lifesaver. It could even lead to the outright eradication of cervical cancer. Continue to Article

HPV Vaccines are Reducing Infections, Warts-- Probably Cancer

An analysis covering 66 million young people has found plummeting rates of precancerous lesions and genital warts after vaccination against the human papillomavirus.

How to talk to parents about HPV vaccines

What if scientists created a vaccine to prevent cancer but the public largely ignored it? Sadly, that’s where we are with the human papillomavirus, or HPV, vaccine, one of the few preventive cancer vaccines in existence. Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversation.

Vaccine reduces HPV prevalence among teen girls by 86% in 10 years

Within 10 years of vaccine introduction, HPV prevalence decreased 86% among females aged 14 to 19 years in the United States, and 71% in women aged 20 to 24 years, according to study findings presented at the CDC’s Epidemic Intelligence Service, or EIS, conference.

HPV Vaccine Driving Down Cervical Pre-Cancer Rates

The human papillomavirus (HPV) vaccine is largely responsible for a decline in precancerous cervical lesions among young women in the United States, a new government report shows.

The number of these precancerous lesions detected during screening went down from an estimated 216,000 cases in 2008 to 196,000 cases in 2016, researchers from the U.S. Centers for Disease Control and Prevention found.

Dating after 40? The millions who are should get the HPV vaccine

The HPV vaccine is important for preteens and teenagers. What about older women?

‘Is Gardasil 9 right for me?” my patient asked during a recent office visit.

She is 45, recently divorced from her husband of 20 years and crafting her online dating profile. She’s also wondering whether she is a candidate for the vaccine that protects against nine strains of the human papilloma virus (HPV) — a virus that causes most cervical, oral and anal cancer.

Controversial HPV Vaccine Shown to be Highly Effective in Wiping Out Cervical Cancer

According to the U.S. Centers for Disease Control and Prevention (CDC), rates of CIN2+ (which are high-grade cervical lesions that can become cancer, and are used to measure HPV vaccine impact) declined from 216,000 women in 2008 to 196,000 women in 2016. Over two-thirds of these lesions were linked to one of the nine strains of HPV that the Gardasil 9 vaccine targets.

HPV vaccination ramp up: Where could we be in 50 years?

An Educational Intervention to Improve HPV Vaccination: A Cluster Randomized Trial

Educational interventions delivered within a clinical setting hold promise to improve vaccination behaviors.

No Ovarian Failure Risk After HPV Vaccine, Study Finds

Reduced ovarian function in teen girls is not a potential effect of teen vaccination, found a new study.


Fear of encouraging sexual activity is not a common reason why parents avoid immunizing their kids against the sexually transmitted human papillomavirus, according to a new survey analysis.

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

No Ovarian Failure Risk After HPV Vaccine, Study Finds

No increased risk of primary ovarian insufficiency in girls occurred after they received the HPV, Tdap (tetanus-diphtheria-acellular pertussis), MenACWY (four meningococcal disease types) or inactivated flu vaccines, the Pediatrics study found.

HPV vaccine cuts cancer-causing infection

There has been a significant fall in the number of cases of HPV, the virus that causes cervical cancer, following the introduction of a vaccine for young women, a new study says.

HPV Vaccine Cuts Cancer Causing Infection

Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds

HPV vaccines prevent cervical cancer, global review confirms

Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination

Disseminating this intervention widely among primary care professionals could substantially increase national adolescent HPV vaccination levels, particularly among boys.

Effect of Health Care Professional Communication Training on Adolescent HPV

Florida man shares story of how he survived HPV cancer

Jason Mendelsohn was pondering a question during a financial exam in 2014 when his fingers grazed his neck, making him notice a bump he hadn’t felt before.

He consulted his father, a doctor, who told him they’d need to call an ear, nose and throat physician. This led to a doctor’s consultation, which eventually led to a diagnosis. At 44, he was told he had HPV-related throat cancer.

Cancer Prevention Through HPV Vaccination in Your Practice: An Action Guide for Nurses and Medical Assistants

A link to an action guide for providers.

Cancer Prevention Through HPV Vaccination: An Action Guide for Large Health Systems

A link to an action guide for providers.

CDC recommends only two HPV shots for younger adolescents

CDC today recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses to protect against cancers caused by human papillomavirus (HPV) infections. Teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.

HPV Sharply Reduced in Teenage Girls Following Vaccine, Study Says

A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said Monday.

Gardasil 9 Indication Now Covers More Male Patients

Merck announced that the Food and Drug Administration (FDA) has expanded the age indication for Gardasil 9 (human papillomavirus 9-valent vaccine [recombinant]) in males. It now includes use in males aged 16–26 for the prevention of anal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 59; precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; and genital warts caused by HPV types 6 and 11.

PAS: Communication style influences HPV vaccination

More adolescents received the HPV vaccine when the vaccine was discussed in the context of other vaccines, and when the providers said they expected that the vaccine would be administered at the visit, results from a multisite study suggest.

Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage

Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness.

Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study

The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls.

HPV vaccine safe for teens, provides long-term benefits

"When administered to adolescents, the HPV4 vaccine demonstrated durability in clinically effective protection and sustained antibody titers over eight years," concluded the researchers.

Scandinavia study finds HPV vaccine safe

A new study from the Karolinska Institutet in Sweden found no association between the human papillomavirus (HPV) vaccine and short- or long-term health concerns.